Related references
Note: Only part of the references are listed.Long-term imatinib therapy promotes bone formation in CML patients
Stephen Fitter et al.
BLOOD (2008)
Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism
Andrew Grey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Imatinib as a potential antiresorptive therapy for bone disease
Andrea L. Dewar et al.
BLOOD (2006)
Altered bone and mineral metabolism in patients receiving imatinib mesylate
E Berman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
